Remifentanil 5 MG vials
Ended Awarded
- Contract number
- SPE2DR26FQN3F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,618
Award facts
- Contract value 100% obligated
- $19,618.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Remifentanil 5 mg vials under a firm fixed-price contract valued at $19,618.24, with an ultimate completion date of October 23, 2025. This non-competitive, non-set-aside delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across the Defense Logistics Agency's medical supply chain. The company maintains a robust portfolio of federal contracts involving delivery orders with firm fixed pricing, demonstrating its capability to fulfill diverse medical supply requirements across multiple therapeutic domains. Remifentanil, an opioid analgesic, is a critical pharmaceutical product for acute pain management in military and veteran healthcare systems, making this supply order consistent with the company's established role as a primary provider of specialty medications and controlled substances to the Department of Defense healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DR26FQN3F?
SPE2DR26FQN3F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DR26FQN3F worth?
The government has obligated $19,618 on SPE2DR26FQN3F.
Is contract SPE2DR26FQN3F an order under another contract?
Yes. SPE2DR26FQN3F is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQN3F competed?
The extent of competition for SPE2DR26FQN3F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award